These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25226087)

  • 1. Cyclic adenosine 5'-diphosphate ribose analogs without a "southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.
    Swarbrick JM; Graeff R; Zhang H; Thomas MP; Hao Q; Potter BV
    J Med Chem; 2014 Oct; 57(20):8517-29. PubMed ID: 25226087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template.
    Moreau C; Liu Q; Graeff R; Wagner GK; Thomas MP; Swarbrick JM; Shuto S; Lee HC; Hao Q; Potter BV
    PLoS One; 2013; 8(6):e66247. PubMed ID: 23840430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose".
    Watt JM; Graeff R; Thomas MP; Potter BVL
    Sci Rep; 2017 Nov; 7(1):16100. PubMed ID: 29170518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38.
    Liu Q; Kriksunov IA; Graeff R; Lee HC; Hao Q
    J Biol Chem; 2007 Feb; 282(8):5853-61. PubMed ID: 17182614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.
    Kirchberger T; Wagner G; Xu J; Cordiglieri C; Wang P; Gasser A; Fliegert R; Bruhn S; Flügel A; Lund FE; Zhang LH; Potter BV; Guse AH
    Br J Pharmacol; 2006 Oct; 149(4):337-44. PubMed ID: 16967053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-
    Watt JM; Graeff R; Potter BVL
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalysis-associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog.
    Liu Q; Kriksunov IA; Moreau C; Graeff R; Potter BV; Lee HC; Hao Q
    J Biol Chem; 2007 Aug; 282(34):24825-32. PubMed ID: 17591784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38.
    Graeff R; Liu Q; Kriksunov IA; Kotaka M; Oppenheimer N; Hao Q; Lee HC
    J Biol Chem; 2009 Oct; 284(40):27629-36. PubMed ID: 19640843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers.
    Watt JM; Thomas MP; Potter BVL
    Sci Rep; 2018 Oct; 8(1):15268. PubMed ID: 30323284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD38.
    Tohgo A; Takasawa S; Noguchi N; Koguma T; Nata K; Sugimoto T; Furuya Y; Yonekura H; Okamoto H
    J Biol Chem; 1994 Nov; 269(46):28555-7. PubMed ID: 7961800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a new N-9 ribityl analogue of cyclic inosine diphosphate ribose (cIDPR) as a mimic of cyclic ADP ribose (cADPR).
    Oliviero G; Amato J; Varra M; Piccialli G; Mayol L
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):735-8. PubMed ID: 16248026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic ADP-ribose requires CD38 to regulate the release of ATP in visceral smooth muscle.
    Durnin L; Mutafova-Yambolieva VN
    FEBS J; 2011 Sep; 278(17):3095-108. PubMed ID: 21740519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic ADP-ribose and its metabolic enzymes.
    Lee HC; Graeff R; Walseth TF
    Biochimie; 1995; 77(5):345-55. PubMed ID: 8527488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a major enzyme for the synthesis and hydrolysis of cyclic ADP-ribose in amphibian cells and evolutional conservation of the enzyme from human to invertebrate.
    Ikeda T; Takasawa S; Noguchi N; Nata K; Yamauchi A; Takahashi I; Yoshikawa T; Sugawara A; Yonekura H; Okamoto H
    Mol Cell Biochem; 2012 Jul; 366(1-2):69-80. PubMed ID: 22422046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase.
    Tohgo A; Munakata H; Takasawa S; Nata K; Akiyama T; Hayashi N; Okamoto H
    J Biol Chem; 1997 Feb; 272(7):3879-82. PubMed ID: 9020087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.
    Franco L; Guida L; Bruzzone S; Zocchi E; Usai C; De Flora A
    FASEB J; 1998 Nov; 12(14):1507-20. PubMed ID: 9806760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity.
    Graeff RM; Walseth TF; Fryxell K; Branton WD; Lee HC
    J Biol Chem; 1994 Dec; 269(48):30260-7. PubMed ID: 7982936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.
    Ikehata F; Satoh J; Nata K; Tohgo A; Nakazawa T; Kato I; Kobayashi S; Akiyama T; Takasawa S; Toyota T; Okamoto H
    J Clin Invest; 1998 Jul; 102(2):395-401. PubMed ID: 9664081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) activity by reverse-phase HPLC.
    Kirchberger T; Guse AH
    Cold Spring Harb Protoc; 2013 Jun; 2013(6):569-73. PubMed ID: 23734017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP.
    Takasawa S; Tohgo A; Noguchi N; Koguma T; Nata K; Sugimoto T; Yonekura H; Okamoto H
    J Biol Chem; 1993 Dec; 268(35):26052-4. PubMed ID: 8253715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.